The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 4.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (24 analysts) rates it buy, with a mean price target of $20.
Norwegian Cruise Line Holdings
NCLH · a US exchange · USD · Market cap $8.6B · 44,500 employees
Norwegian Cruise Line Holdings Ltd., together with its subsidiaries, operates as a cruise company in North America, Europe, the Asia-Pacific, and internationally.
FAIL · Does not pass the screenPrice as of 18 Nov 2026Daily close, not a live quote
Screened 2026-11-18 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price17.99 USD at the 18 Nov 2026 close
- Our value readOvervalued vs our fair value, as of 18 Nov 2026
- Our regime readMarkup, as of 15 Nov 2026
- Ethical screenDoes not pass
- OptionsOpen interest leans heavily to calls (put/call 0.38)
- Last reviewed18 Nov 2026 (2 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $11.70 to $18.58, base estimate $16.15 (screen dated 2026-11-18).
- Trend Markup
- Insiders no filings inside 60 days, left as found
- Positioning political buying, disclosed 2026-10-20
- Options put/call open interest 0.38, read 2026-11-18
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markup label.
Norwegian Cruise Line Holdings holds its Markup at $17.99. The statistical read favours the sellers, held for 15 days.
| Phase | Markup |
| Quantitative state | The statistical read favours the sellers, held for 15 days |
| Price at the screen | $17.99 |
| Valuation | 10.40 trailing · 13.23 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 1.96 |
Five Screens: NCLH's Results
FAIL. Debt ratio
| Test | Figure | Limit | Status |
|---|---|---|---|
| Business activity | Permissible | Permissible core business | Pass |
| Debt load | 64.80% | Below 33% | Fail |
| Interest-bearing cash | 0.00% | Below 33% | Pass |
| Receivables | 2.23% | Below 49% | Pass |
Definitions, sources and threshold rules: ticker values-screen methodology.
The Ethical ReadWhy It Falls Short, in Plain English
Norwegian Cruise Line's business is in a permissible area, but its interest-bearing debt is about 65% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when NCLH's ethical verdict changes
Today NCLH does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Overvalued vs our fair value, as of 18 Nov 2026: it trades above our $16.15 fair value estimate, narrow competitive moat, 0.30% revenue growth.
Model construction and limits: fair-value methodology.
Fair value range in USD, drawn from the 2026-11-18 screen. The gold marker is the market price at the same screen. The price runs 11.4% above the base estimate.
Third-party analyst targets: 24 covering, consensus Buy. The average target sits +8% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere our models see it going: fair-value estimate $16.15, with a range of $11.70 to $18.58, dated to the 2026-11-18 screen.
How our estimate and third-party targets differ.
The Business, in Plain WordsCruise line's cheap price hides heavy debt
Picture a packed ship leaving port with the hull already taking on water. Norwegian Cruise Line shows solid revenue growth and a 30 percent return on equity, yet the business carries debt levels that trip our ethical screen outright. That leaves little room for the unexpected storms the sector faces every cycle.
The narrow moat and 9.6 times forward earnings create the look of value, but this is exactly the cyclical trap where peak earnings meet a low multiple. Revenue expansion at 10 percent and thin 6 percent margins offer scant buffer once bookings soften, and the ethical debt failure rules the name out regardless of analyst targets.
Consensus buy ratings ignore the structural leverage that remains after the pandemic. Any fresh slowdown in travel demand would expose how little protection sits beneath those headline numbers.
Analysis, not advice.
| Forward P/E | 13.2xexpensive even after accounting for its growth |
| Trailing P/E | 10.4xreasonably valued |
| EPS, trailing | 1.81 |
| EPS, forward | 1.42 |
| Revenue growth | +0.3%slow but positive growth |
| Profit margin | 8.2%thin but positive margins |
| Return on equity | 31.2%an exceptional return on shareholder capital |
| FCF yield | -12.11% |
| Debt to equity | 5.09heavy leverage: higher risk if revenue softens |
| Current ratio | 0.23below 1: short-term bills exceed liquid assets |
| Beta | 1.96much more volatile than the market |
| Short interest, float | 0.20% |
| 52-week range | 13.63 - 25.13 |
| Moat | NARROW |
| Market cap | $8.6B |
| Employees | 44,500 |
NCLH-specific watchpoints · The things to watch: it already moves more than the market on an average day; it carries a real debt load, which raises the stakes if revenue slips.
Metric definitions and interpretation rules: ticker-page methodology.
Every Entry, As Written
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 1.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (24 analysts) rates it buy, with a mean price target of $20.
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 23.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (23 analysts) rates it buy, with a mean price target of $20.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (24 analysts) rates it buy, with a mean price target of $19. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (24 analysts) rates it buy, with a mean price target of $19. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (24 analysts) rates it buy, with a mean price target of $19. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (24 analysts) rates it buy, with a mean price target of $19. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (24 analysts) rates it buy, with a mean price target of $19. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (24 analysts) rates it buy, with a mean price target of $19. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (24 analysts) rates it buy, with a mean price target of $19. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Can NCLH's $325M Savings Plan Drive a Margin Recovery in 2027? Yahoo Finance · 7d ago
- Can Carnival's Lower Fuel Consumption Offset Rising Energy Costs? Yahoo Finance · 7d ago
- What Could Surprise Carnival Stock Investors On The Upside? Yahoo Finance · 9d ago
- CCL Stock Gains 16% in a Month: Should You Buy Now or Hold Steady? Yahoo Finance · 9d ago
- Averting Proxy Wars: 5 Companies Opting for Activist Investor Settlements Yahoo Finance · 10d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-19 | CIL JOSE E | Director | 15,000 | $225,350 | |
| 2026-05-11 | MACDONALD BRIAN P | Director | 15,000 | $248,100 | |
| 2026-05-07 | BYNG-THORNE ZILLAH | Director | 29,467 | $521,394 | |
| 2026-05-07 | LANSBERRY KEVIN ALLEN | Director | 11,400 | $196,992 | |
| 2026-04-13 | MACDONALD BRIAN P | Director | 8,912 | · | |
| 2026-04-13 | PAGLIUCA STEPHEN G | Director | 8,912 | · | |
| 2026-04-13 | COHEN JONATHAN Z | Director | 8,912 | · | |
| 2026-04-13 | CRUZ ALEX | Director | 8,912 | · | |
| 2026-04-13 | LANSBERRY KEVIN ALLEN | Director | 8,912 | · | |
| 2026-03-26 | CHIDSEY JOHN W | Chief Executive Officer | 967,254 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-10-20 | Gil Cisneros | Democrat | buy | 1K–15K |
| 2026-10-13 | Ro Khanna | Democrat | buy | 1K–15K |
| 2025-02-07 | Tim Walberg | Republican | buy | 15K–50K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $15.24 | +18.0% | · | $1,180 | +18.0% |
| 2 months | $14.12 | +27.4% | · | $1,274 | +27.4% |
| 3 months | $16.75 | +7.4% | · | $1,074 | +7.4% |
| 6 months | $16.30 | +10.4% | · | $1,104 | +10.4% |
| 1 year | $17.84 | +0.8% | · | $1,008 | +0.8% |
| 2 years | $26.10 | -31.1% | · | $689 | -31.1% |
| 3 years | $14.93 | +20.5% | · | $1,205 | +20.5% |
| 5 years | $23.09 | -22.1% | · | $779 | -22.1% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever NCLH does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.